Bruce J Giantonio MD
Associate Professor, Medicine, Perelman School of Medicine
Join to View Full Profile
3400 Spruce St15 Penn TowerPhiladelphia, PA 19104
Phone+1 215-662-3914
Dr. Giantonio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
University of Vermont Medical CenterResidency, Internal Medicine, 1987 - 1990
Georgetown University School of MedicineClass of 1987
Certifications & Licensure
MA State Medical License 2017 - 2026
NH State Medical License 2024 - 2024
ME State Medical License 2020 - 2021
PA State Medical License 1990 - 2021
VT State Medical License 1987 - 1990
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Combination Chemotherapy Plus Bevacizumab in Treating Patients With Advanced Colorectal Cancer Start of enrollment: 2000 Nov 01
- Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated Start of enrollment: 2001 Sep 01
- Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer Start of enrollment: 2003 Oct 15
- Join now to see all
Publications & Presentations
PubMed
- Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation.Daniel W Kim, Grace Lee, Elise M Cai, David P Ryan, Aparna R Parikh
Cancer Journal. 2025-01-22 - 4 citationsPrognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.Romain Cohen, Morteza Raeisi, Benoist Chibaudel, Qian Shi, Takayuki Yoshino
European Journal of Cancer. 2024-08-01 - 4 citationsPatient-Reported Outcomes, Tumor Markers, and Survival Outcomes in Advanced GI Cancer.Joy X Jarnagin, Anurag Saraf, Islam Baiev, Gary Chi, Emily E van Seventer
JAMA Network Open. 2023-11-01
Authored Content
- A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
- A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
- A New Look at the International Duration Evaluation of Adjuvant Therapy (IDEA) Classification—Defining Novel Predictive and Prognostic Markers in Stage III Colon CancerMay 2018
Press Mentions
Donegal Woman Finally Starts Lifesaving Cancer Treatment in USAugust 18th, 2021
Racial Disparities in Colon Cancer Survival PersistDecember 30th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
